Chris Crawford, CEO of RxSaveCard, dives into the murky waters of pharmacy benefits and inflated drug prices. He shines a spotlight on the hidden costs imposed by large Pharmacy Benefit Managers (PBMs) and discusses a significant lawsuit involving J&J. Crawford explains how aggregate discount guarantees often lead to higher prices for consumers, while cash-pay options can offer real savings. The conversation encourages transparency in drug pricing and highlights innovative tools that help both employers and employees navigate the complex pharmaceutical landscape.

In this conversation, Chris Crawford, CEO of RxSaveCard, delves into the complex world of GLP-1 medications and the financial dilemmas faced by plan sponsors. He discusses how trying to limit medication volume can paradoxically lead to higher unit costs. Chris explores innovative solutions in the burgeoning cash marketplace, allowing employers to bypass traditional PBM contracts for better pricing. Tune in for insights on navigating pharmacy trends and leveraging alternative strategies to manage healthcare costs effectively.